Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells from implant hole via the ERK1/2 pathway.

What is the context? Bone defects caused by trauma or tumor is a great challenge in clinical practice. However, there is the good news that the bone defect in the oral can self-regenerate, the bone remodeling may take several months to several years and shows apparent individual differences.Different strategies, surgical techniques, and materials have been employed to induce an optimal outcome in guided bone regeneration.Blood products have been widely used in dentistry due to their excellent biocompatibility, growth factor content, ease of collection, and ability to be produced by the human body.Limited data suggest that Injectable platelet-rich fibrin positively regulates osteogenic differentiation of stem cells, but further evidence is needed to quantify this effect.What is new? It is unclear how many growth factors i-PRF contains in previous studies, so we detected 41 kinds of growth factors, more than has been previously appreciated, and found that all growth factors were measured in the samples, and the difference was in the amount of expression.In our research, we explored the role of i-PRF in the osteogenesis of hBMSCs through the effects of different concentrations of i-PRF on the proliferation, migration, and osteogenic differentiation of hBMSCs.Currently, most current research focuses on observing phenomena, and we wondered by what mechanism the i-PRF regulates stem cell function. We found that i-PRF can regulate the molecular mechanism of the osteogenic differentiation of hBMSCs in vitro by activating the MAPK/ERK signaling pathway.What is the impact?I-PRF promotes hBMSCs proliferation and migration and facilitates cell osteogenesis through the ERK pathway. The favorable cytobiological effects of i-PRF on hBMSCs might be the basis for i-PRF applications in bone regenerative.